Related Experiment Videos
[Dysfunctional uterine bleeding: medical therapies]
1II Clinica Ostetrica e Ginecologica, Dipartimento di Ostetricia e Ginecologia e Scienze Radiologiche, Università degli Studi di Catania, Catania, P.O. Ascoli-Tomaselli di Catania, Catania, Italy. corradomorana@infinito.it
Minerva Ginecologica
|October 29, 2003
Summary
Abnormal uterine bleeding (AUB) is common in gynecology. Evidence-based medical treatments for dysfunctional uterine bleeding (DUB) improve patient satisfaction and reduce hysterectomy costs.
Area of Science:
- Gynecology
- Reproductive Endocrinology
Context:
- Abnormal uterine bleeding (AUB) accounts for a significant portion of gynecological consultations, particularly in peri- and postmenopausal women.
- Dysfunctional uterine bleeding (DUB), often linked to chronic anovulatory conditions, requires a thorough diagnostic process to exclude organic pathologies.
Purpose:
- To outline evidence-based medical treatments for dysfunctional uterine bleeding (DUB).
- To emphasize the importance of excluding organic causes before diagnosing DUB.
Summary:
- Common treatments for DUB include medications such as methylergometrine, antifibrinolytics, NSAIDs, hormonal therapies (estrogens, progestins, estroprogestins), danazol, and GnRH analogues.
- The diagnostic workup for DUB involves transvaginal echography, sonohysterography, hysteroscopy, and potentially biopsy.
Impact:
- Adherence to evidence-based guidelines for DUB management enhances patient satisfaction.
- Effective medical management of DUB leads to a notable reduction in healthcare costs, primarily through decreased rates of hysterectomy.